BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo.

Authors

Yanqin Ren
Szu-Han Huang
Shabnum Patel, George Washington University
Winiffer D. Conce Alberto
Dean Magat
Dughan J. Ahimovic
Amanda B. Macedo, George Washington University
Ryan Durga, George Washington University
Dora Chan, George Washington University
Elizabeth Zale
Talia M. Mota
Ronald Truong, George Washington University
Thomas Rohwetter, George Washington University
Chase D. McCann
Colin M. Kovacs
Erika Benko
Avery Wimpelberg
Christopher M. Cannon
W David Hardy
Alberto Bosque, George Washington University
Catherine M. Bollard, George Washington University
R Brad Jones

Document Type

Journal Article

Publication Date

2-6-2020

Journal

The Journal of Clinical Investigation

DOI

10.1172/JCI132374

Comments

Online ahead of print

APA Citation

Ren, Y., Huang, S., Patel, S., Conce Alberto, W. D., Magat, D., Ahimovic, D. J., Macedo, A. B., Durga, R., Chan, D., Zale, E., Mota, T. M., Truong, R., Rohwetter, T., McCann, C. D., Kovacs, C. M., Benko, E., Wimpelberg, A., Cannon, C. M., Hardy, W., Bosque, A., Bollard, C. M., & Jones, R. (2020). BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo.. The Journal of Clinical Investigation, (). http://dx.doi.org/10.1172/JCI132374

Peer Reviewed

1